fbpx

FYidoctors Adds Clinic in Lloydminster

FYidoctors announced its merger with The Eyewear Place, located in Lloydminster, Alberta. The addition marks the second clinic merger in the province in recent months, and the first FYidoctors clinic in the city of Lloydminster.

Established in 2002, the practice is led by Dr. Cory Larson and includes a team of skilled vision care professionals including Candace Florizone, Paula Phillips, and Chelsey Mader. Dr. Larson completed his Bachelor of Science from the University of Alberta in 2010, and his Doctor of Optometry from Midwestern University Arizona College of Optometry in 2014. He brings to the clinic a wide variety of experience in optometric specialties, having spent his final year of clinical rotations in several diverse optometry practices across the United States.

“We are a high-volume clinic that the community has come to depend on for all of their vision care needs over the last 20 years. We take tremendous pride in our patient-centric delivery and are excited to add to that with this partnership with FYidoctors,” said Dr. Larson. “From access to cutting-edge technology to marketing support to exclusive frame styles, our patients are truly the ones who will benefit from what FYidoctors bring to the merger.”

The Eyewear Place has been involved in several local causes, spearheaded by optician, Paula Phillips, including annual fundraising initiatives for the MS Society of Canada, and a holiday drive for the Salvation Army.

“We’re excited to welcome Dr. Larson and the team at The Eyewear Place to the FYidoctors’ growing team of optometric professionals,” said Dr. Alan Ulsifer, CEO and Chairman of FYidoctors. “The practice is known for its commitment to comprehensive vision care and we look forward to building on this together through this exciting new partnership.”

Click HERE for the full press release.

Other related articles

Creative Frames from The Big Easy

In the March-April issue of Optik Magazine, contributor Jean-François Venne presents Creative Director and Founder of KREWE Eyewear, Stirling Barrett, who wanted to create frames that were inspired by the bustling culture and southern vibe of New Orleans.

Stirling Barrett studied in creative advertising at the Southern Methodist University, in Dallas, just prior to founding KREWE. Eyewear design had long been an interest of his, but in 2013, when he decided to begin KREWE, is when he truly became involved in the industry.

KREWE kicked off in August 2013. Stirling knew he wanted to build something that changed the way people interacted and thought about New Orleans and build a brand for the people of New Orleans.

Find out what makes KREWE’s frames stand apart from other frames and much more by checking out the full interview by Jean-François Venne available in the March-April issue of Optik Magazine.

Check out more articles from Jean-François Venne HERE!

Novartis Canada Named a Top 50 Best Workplace in the Country

Novartis Pharmaceuticals Canada has been recognized as a Great Place to Work® and announces that Novartis in Canada has earned a spot on the “Top 50 Best Workplaces™” in the country. Novartis has also been named on the 2021 list of Best Workplaces™ for Women, a designation that speaks to the organization’s inclusive and equitable work environment.

The Top 50 Best Workplaces™ list is curated based on analyzed responses from thousands of individuals from organizations in Canada with more than 1,000 employees working in Canada or worldwide. 

“What makes me very proud about these designations is that it is our associates who provide their feedback, and they are telling us that our ‘care in leadership’ approach is appreciated. Our leaders didn’t underestimate the challenges that were faced in 2020 and focused on prioritizing the wellbeing of our associates to ensure, among other things, work-life balance. I would like to express my gratitude to the team for their steadfast dedication to reimagining medicine and continuing to deliver for patients no matter what,” said Christian Macher, Country President, Novartis Pharmaceuticals Canada Inc.

The highly respected recognition program run by the Great Place to Work® Institute gathers and evaluates employee feedback and acknowledges companies who have built high-trust, high-performance workplace cultures. The list evaluates like-sized companies from across Canada that are measured against criteria designed to identify those that are exceptional places to work. Novartis associates were surveyed and gave feedback on the following five areas: credibility, respect, fairness, pride and camaraderie.

Click HERE for the full press release.

Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 (perfluorohexyloctane) as a first-in-class eye drop with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD).

The GOBI trial met both of its co-primary endpoints, including:

  • Change from baseline in total Corneal Fluorescein Staining (tCFS), a measure of assessing damage to the eye, achieved statistical significance at day 15 (secondary endpoint), with continued results through day 57 (primary endpoint) compared to control;
  • Change from baseline in dryness score achieved statistical significance at day 15 (secondary endpoint), with continued results through day 57 (primary endpoint) compared to control, as rated on a visual analogue scale (VAS) ranging from 0-100 (0 = no discomfort; 100 = maximum discomfort).

The GOBI trial also met all of its secondary endpoints, showing statistically significant improvements in both the signs and symptoms of DED associated with MGD that were studied.

“There is currently no pharmaceutical therapy available in the United States for the treatment of dry eye disease associated with meibomian gland dysfunction,” said Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb. “These outstanding topline results are very encouraging that we may be able to bring this first-in-class treatment option to market for the millions of patients who have dry eye disease associated with meibomian gland dysfunction.”

“I am very impressed by the positive results from this first Phase 3 study of NOV03, in particular the findings at day 15 in treating the signs and symptoms of the disease,” said Joseph Tauber, M.D., founder of Tauber Eye Center in Kansas City, Mo., and trial investigator. “These findings validate the importance of the continued development of NOV03, and I look forward to seeing additional results from the Phase 3 program.”

The Phase 3 program for NOV03 includes an ongoing second Phase 3, multi-center, randomized, double-masked, saline-controlled trial (MOJAVE study) and a multi-center, open-label, single-arm 12-month safety extension trial (KALAHARI study). Topline results from MOJAVE, if positive, will allow for a filing to the U.S Food and Drug Administration in 2022.

Click HERE for the full press release.

Related:
Bausch Advances Novel Dry Eye Therapeutic to Phase 3

Featured Posts

Orthokeratologists ROCKSTARS’ PRE-LAUNCH CAMPAIGN

Orthokeratologist.org Launches Global Community to Unite Orthokeratologists Worldwide

Orthokeratologist.org launches the first global community for orthokeratologists, inviting practitioners worldwide to register, connect and help advance the future of ortho k.

Learn More
SightGlass DOT logos 2026

Canadian Webinar Series Connects Contrast Management Evidence with Real‑World Myopia Control for Children

SightGlass Vision will host a Canadian webinar exploring real world pediatric cases and evidence supporting contrast based myopia control using DOT spectacle lenses.

Read more
HOYA Vision Care Logo 2026

HOYA Vision Care, Canada Announces the Launch of HOYA LensPreview™ Virtual Try-On for Photochromic, Polarized, and Mirror Lenses

HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.

Read more
Opticians and Contact Lens Care

Opticians See Stronger Role in Contact Lens Wear and Care

A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.

Read more
National Association of Optical Goods Manufacturers ANFAO logo

Italian Eyewear Exports Show Early Signs of Recovery in First Half of 2026

Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.

Read more
Orthokeratologists ROCKSTARS’ PRE-LAUNCH CAMPAIGN

Orthokeratologist.org Launches Global Community to Unite Orthokeratologists Worldwide

Orthokeratologist.org launches the first global community for orthokeratologists, inviting practitioners worldwide to register, connect and help advance the future of ortho k.

Learn More
SightGlass DOT logos 2026

Canadian Webinar Series Connects Contrast Management Evidence with Real‑World Myopia Control for Children

SightGlass Vision will host a Canadian webinar exploring real world pediatric cases and evidence supporting contrast based myopia control using DOT spectacle lenses.

Read More
HOYA Vision Care Logo 2026

HOYA Vision Care, Canada Announces the Launch of HOYA LensPreview™ Virtual Try-On for Photochromic, Polarized, and Mirror Lenses

HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.

Read More
Opticians and Contact Lens Care

Opticians See Stronger Role in Contact Lens Wear and Care

A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.

Read More
National Association of Optical Goods Manufacturers ANFAO logo

Italian Eyewear Exports Show Early Signs of Recovery in First Half of 2026

Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.

Read More
Orthokeratologists ROCKSTARS’ PRE-LAUNCH CAMPAIGN

Orthokeratologist.org Launches Global Community to Unite Orthokeratologists Worldwide

Orthokeratologist.org launches the first global community for orthokeratologists, inviting practitioners worldwide to register, connect and help advance the future of ortho k.

Learn More
SightGlass DOT logos 2026

Canadian Webinar Series Connects Contrast Management Evidence with Real‑World Myopia Control for Children

SightGlass Vision will host a Canadian webinar exploring real world pediatric cases and evidence supporting contrast based myopia control using DOT spectacle lenses.

Read more
HOYA Vision Care Logo 2026

HOYA Vision Care, Canada Announces the Launch of HOYA LensPreview™ Virtual Try-On for Photochromic, Polarized, and Mirror Lenses

HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.

Read more
Opticians and Contact Lens Care

Opticians See Stronger Role in Contact Lens Wear and Care

A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.

Read more
National Association of Optical Goods Manufacturers ANFAO logo

Italian Eyewear Exports Show Early Signs of Recovery in First Half of 2026

Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.

Read more
Orthokeratologists ROCKSTARS’ PRE-LAUNCH CAMPAIGN

Orthokeratologist.org Launches Global Community to Unite Orthokeratologists Worldwide

Orthokeratologist.org launches the first global community for orthokeratologists, inviting practitioners worldwide to register, connect and help advance the future of ortho k.

Learn More
SightGlass DOT logos 2026

Canadian Webinar Series Connects Contrast Management Evidence with Real‑World Myopia Control for Children

SightGlass Vision will host a Canadian webinar exploring real world pediatric cases and evidence supporting contrast based myopia control using DOT spectacle lenses.

Read more
HOYA Vision Care Logo 2026

HOYA Vision Care, Canada Announces the Launch of HOYA LensPreview™ Virtual Try-On for Photochromic, Polarized, and Mirror Lenses

HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.

Read more
Opticians and Contact Lens Care

Opticians See Stronger Role in Contact Lens Wear and Care

A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.

Read more
National Association of Optical Goods Manufacturers ANFAO logo

Italian Eyewear Exports Show Early Signs of Recovery in First Half of 2026

Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.

Read more